Countless women and some high-risk men undergo breast cancer screenings each year, hoping for peace of mind and early detection. Yet, despite the widespread use of mammography, many cancers still go undetected until later stages. A groundbreaking study from Yale Cancer Center found a promising solution: Digital Breast Tomosynthesis (DBT).
What Is Digital Breast Tomosynthesis?
DBT is a 3D imaging technique that could improve how we detect breast cancer. According to the researchers, DBT has more advantages than conventional 2D mammography, most notably by delivering more accurate and earlier cancer detection. This breakthrough analysis, which spans over 13 years of screening data, has superior detection capabilities that may reduce the incidence of advanced cancer diagnoses. As DBT technology continues to gain traction, these findings could have a lasting impact on how we screen and treat breast cancer moving forward.
How Does Digital Breast Tomosynthesis Work?
Digital Breast Tomosynthesis, often referred to as 3D mammography, is a leap forward in breast cancer screening technology. Unlike traditional 2D mammography, which captures images from just two angles, DBT takes several images of the breast from multiple angles before reconstructing them into a three-dimensional view. This technology lets radiologists examine the breast tissue layer by layer, resulting in a clearer, more detailed picture of the breast’s internal structure.
Key Findings from Yale Cancer Center’s 13-Year Study
Yale Cancer Center’s researchers emphasized the following benefits of Digital Breast Tomosynthesis:
Higher Cancer Detection Rate
The study, which tracked 1,407 breast cancer cases and over 270,000 screenings, found that DBT outperforms traditional 2D mammography in several areas. The most notable finding was the higher cancer detection rate with DBT. It detected 5.3 cancers per 1,000 screenings, compared to 4 per 1,000 for 2D mammography. This difference, while seemingly small, could have a substantial impact on early detection, where catching cancers sooner leads to more treatment options and better outcomes.
Lower False Positive Rate
In addition to improving cancer detection, DBT also demonstrated a lower false positive rate. Women who underwent DBT screenings had a 7.2% recall rate—meaning they were called back for additional tests after a screening found a non-cancerous abnormality—compared to a 10.6% recall rate for those who had traditional 2D mammograms. Fewer false positives mean less stress, fewer unnecessary tests, and greater confidence in the results.
Reduced Advanced Cancer Diagnoses
Perhaps most importantly, the study suggests that DBT may cut the number of advanced cancer diagnoses. By identifying cancers at earlier and more treatable stages, patients can receive care before cancer has a chance to progress. Over time, this approach could decrease the number of people diagnosed with advanced-stage breast cancer.
Why Is DBT More Effective?
Digital Breast Tomosynthesis may be a more effective screening tool for breast cancer because it offers a level of detail that traditional 2D mammography simply cannot. DBT’s ability to create 3D images by capturing multiple images of the breast from all angles allows radiologists to check the breast tissue layer by layer. This breakthrough makes it easier to detect abnormalities that might hide in plain sight in a 2D image due to overlapping tissue.
Furthermore, false negatives and positives are common with traditional 2D mammography. With DBT, these issues are less likely. The 3D images provide a clearer picture that allows radiologists to distinguish between malignant tumors and benign tissue. This enhanced clarity also helps doctors diagnose cancer at stages I or II, which often require less aggressive treatments and have better overall prognoses.
In essence, DBT finds more cancers and exposes them at a time when they are more manageable, ultimately leading to better care and less emotional strain for patients. With fewer false negatives or positives, more accurate results, and earlier detection, DBT is the more powerful tool.
Are 3D Mammographs and Tomosynthesis Imaging the Same?
Not all digital mammography machines can perform tomosynthesis imaging, which means that not every facility or screening center has it. DBT has specialized equipment capable of capturing multiple X-rays of the breast from various angles, which are then reconstructed into a 3D image. This additional capability requires major upgrades to existing mammography machines or entirely new systems, which can be costly. As a result, many healthcare providers have yet to implement DBT technology, especially in smaller clinics or areas with limited resources.
Furthermore, integrating DBT into clinical practice involves training radiologists to interpret the 3D images correctly. For these reasons, access to tomosynthesis imaging may remain limited to certain regions or facilities, and patients may need to seek out specialized centers that offer the latest screening technology.
Availability and Ongoing Research
While DBT is available at some facilities, research into its full potential is far from over. Ongoing and future studies aim to deepen our understanding of DBT’s impact on breast cancer detection, treatment outcomes, and long-term patient health.
-
- Integrating AI with DBT: As the technology evolves, future studies will explore how DBT can work with other screening methods or medical advancements, including artificial intelligence, to enhance accuracy and streamline the diagnostic process. For example, AI could improve the speed and precision of diagnoses by helping radiologists identify subtle patterns in 3D images.
- Long-term effects and healthcare integration: Researchers are also eager to determine the long-term impact of widespread DBT adoption. Will it continue to decrease advanced cancer diagnoses? Will DBT’s mass integration into healthcare facilities affect screening guidelines, insurance coverage, and access to care? These are only two of the questions that the scientific and medical communities hope to answer.
As the evidence builds, these studies hold the promise of making Digital Breast Tomosynthesis an even stronger ally against breast cancer.
The Bottom Line
Since DBT separates the overlapping tissue that can sometimes obscure tumors, it can detect small or hidden cancers that traditional 2D images might otherwise miss. Plus, this detailed imaging minimizes the chances of a false alarm, sparing millions from unnecessary follow-up tests and undue anxiety.
“DBT is an effective screening tool that not only finds more cancers, it catches them earlier at a lower stage, which means fewer advanced cancers,” said first author Dr. Liane Philpotts. “Over time, when women have repeated 3D mammograms, the number of advanced cancers diagnosed [could be] even lower.”
